CERIS Expands Services and Rebrands

Rapidly Growing Payment Integrity Firm Offers New Solutions in DRG Validation, Data Mining and More

FORT WORTH, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) — CERIS, a CorVel company and a leader in both prepay and post-pay health care claims review, has expanded services and launched a top to bottom rebranding to communicate its enhanced value proposition.

CERIS has been a leader in prepay itemized bill review for three decades. It has expanded its service offerings to add innovative services such as full DRG validation review and a state-of-the-art methodology to perform fair and appropriate out-of-network repricing.

CERIS also performs post-payment itemized bill review, clinical coding reviews, implant reviews, chart to charge reviews and medical implant and transplant reviews. It brings to bear deep data mining and analytical capabilities that allow it to discover savings in 97% of all claims that it reviews. In implant claims alone, it obtains an average savings of 62% over original bills.

The rebranding includes the articulation of a specific purpose for CERIS: To help heal healthcare billing through transparency and integrity. The company’s overall vision is to become a beacon of integrity in the healthcare industry.

“As our company continues to grow, we revisit our mission and purpose so we remain aligned, relevant and authentic to who we are,” said company President, Greg Dorn. “Our commitment is to be proactive in meeting our clients’ emerging needs and steward our identity with integrity. Our goal is to remain a premier payment integrity partner.”

In addition to its rearticulated purpose and vision, CERIS will emphasize to its clients its dedication to accuracy and transparency in healthcare billing. Its client interactions are focused on integrity, reliability, dedication, professionalism and true partnership.

For more information visit www.ceris.com, and follow us on LinkedIn.

About CERiS

CERIS, a leader in both prospective and retrospective claims review and repricing, combines clinical expertise and cost containment solutions to ensure the accuracy and transparency in healthcare payments. Accuracy and validation services include itemization review, DRG validation, facility repricing, contract and policy applications, review of implants and devices, and primary payer cost avoidance. Its proprietary universal chargemaster contains billions of charge items from more than 97% of the nation’s hospitals, helping to ensure the accuracy and objectivity of each claim review.

About CorVel

CorVel Corp. applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. We partner with employers, third-party administrators, insurance companies and government agencies in managing worker’s compensation and health, auto and liability services. Our diverse suite of solutions combines our integrated technologies with a human touch. CorVel’s customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.

Contact: Melissa Storan
Phone: 949-851-1473
www.corvel.com

Staff

Recent Posts

Signifier Medical Technologies’ eXciteOSA Now Covered by Medicaid in South Carolina: Reaching a Wider Patient Population with Daytime Sleep Apnea Therapy

BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies Limited (“Signifier”), a leader in medical technology for sleep-disordered breathing, is…

2 hours ago

Thryv Therapeutics Inc. Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Montreal, Quebec--(Newsfile Corp. - April 4, 2024) - Thryv Therapeutics Inc., a Montreal based biotechnology…

2 hours ago

MMJ BioPharma Cultivation Sues the DEA once again – Is the DEA a Rogue Agency?

The DEA Games Continue To Delay Legitimate Marijuana Clinical Trials and ResearchWASHINGTON, DC / ACCESSWIRE…

2 hours ago

Oral Cancer Cause Joins with the V Foundation for Cancer Research

LARGO, FL / ACCESSWIRE / April 4, 2024 / Oral Cancer Cause (OCC), a non-profit…

2 hours ago

Annual Report 2023

GOTHENBURG, SWEDEN / ACCESSWIRE / April 4, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Today XVIVO Perfusion…

2 hours ago

New Life Solutions Addresses Florida Court Decision to Bring Major Changes to Abortion Laws

TAMPA, FL / ACCESSWIRE / April 4, 2024 / On April 1, 2024, the Florida…

2 hours ago